Treatment of Locally Recurrent and Metastatic Squamous Cell Carcinoma of Head & Neck

Head and Neck Cancer Research ◽

10.21767/2572-2107.100004 ◽

2016 ◽

Vol 01 (01) ◽

Author(s):

Chukwuemeka V Ikpeazu

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent ◽

Download Full-text

Faculty Opinions recommendation of Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of the head and neck (E1304): a trial of the Eastern Cooperative Oncology Group.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954085.793459863 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Eastern Cooperative Oncology Group ◽

Oncology Group ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Carrier-based intralymphatic cisplatin chemotherapy for the treatment of metastatic squamous cell carcinoma of the head & neck

Therapeutic Delivery ◽

10.4155/tde.10.38 ◽

2010 ◽

Vol 1 (2) ◽

pp. 237-245 ◽

Author(s):

Shuang Cai ◽

Yumei Xie ◽

Neal M Davies ◽

Mark S Cohen ◽

M Laird Forrest

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Squamous Cell ◽

Metastatic Squamous Cell Carcinoma ◽

Download Full-text

Phase II 2-arm trial of the proteasome inhibitor, PS-341 (bortezomib) in combination with irinotecan or PS-341 alone followed by the addition of irinotecan at time of progression in patients with locally recurrent or metastatic squamous cell carcinoma of

Head & Neck ◽

10.1002/hed.23046 ◽

2012 ◽

Vol 35 (7) ◽

pp. 942-948 ◽

Author(s):

Jill Gilbert ◽

Ju Whei Lee ◽

Athanassios Argiris ◽

Missak Haigentz ◽

Lawrence Eric Feldman ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Proteasome Inhibitor ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Combination therapy with docetaxel plus fluorouracil is active in locally recurrent and/or metastatic squamous cell carcinoma of the head and neck

Inpharma Weekly ◽

10.2165/00128413-200414650-00028 ◽

2004 ◽

Vol &NA; (1465) ◽

pp. 12

Author(s):

&NA;

Keyword(s):

Squamous Cell Carcinoma ◽

Combination Therapy ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Randomized Phase Ii Study of Mehd7945A (Mehd) Vs Cetuximab (Cet) in >= 2Nd-Line Recurrent/Metastatic Squamous Cell Carcinoma of the Head & Neck (Rmscchn) Progressive On/After Platinum-Based Chemotherapy (Ptct)

Annals of Oncology ◽

10.1093/annonc/mdu340.1 ◽

2014 ◽

Vol 25 ◽

pp. iv340 ◽

Author(s):

J. Fayette ◽

L.J. Wirth ◽

C. Oprean ◽

R. Hitt ◽

A. Udrea ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Randomized Phase Ii ◽

Platinum Based Chemotherapy ◽

Metastatic Squamous Cell Carcinoma ◽

Download Full-text

Afatinib versus methotrexate as second-line treatment in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck progressing on or after platinum-based therapy (LUX-Head & Neck 1): an open-label, randomised phase 3 trial

The Lancet Oncology ◽

10.1016/s1470-2045(15)70124-5 ◽

2015 ◽

Vol 16 (5) ◽

pp. 583-594 ◽

Author(s):

Jean-Pascal H Machiels ◽

Robert I Haddad ◽

Jérôme Fayette ◽

Lisa F Licitra ◽

Makoto Tahara ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Line Treatment ◽

Second Line ◽

Phase 3 ◽

Metastatic Squamous Cell Carcinoma ◽

Download Full-text

Docetaxel Plus 5-Fluorouracil in Locally Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck

American Journal of Clinical Oncology ◽

10.1097/01.coc.0000136017.13633.b0 ◽

2004 ◽

Vol 27 (5) ◽

pp. 472-476 ◽

Author(s):

Dominique Genet ◽

D Cupissol ◽

G Calais ◽

P Bontemps ◽

H Bourgeois ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Squamous Cell ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Phase II Trial of Interferon-?? in Locally Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck: Immunological and Clinical Correlates

Journal of Immunotherapy ◽

10.1097/00002371-199611000-00008 ◽

1996 ◽

Vol 19 (6) ◽

pp. 433-442 ◽

Author(s):

Daniel R. Vlock ◽

Janet Andersen ◽

Leslie A. Kalish ◽

Jonas T. Johnson ◽

John M. Kirkwood ◽

...

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Clinical Correlates ◽

Metastatic Squamous Cell Carcinoma ◽

Locally Recurrent

Download Full-text

Faculty Opinions recommendation of Phase II study of figitumumab in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck: clinical activity and molecular response (GORTEC 2008-02).

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.14264023.15777137 ◽

2012 ◽

Author(s):

Marco Merlano

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Study ◽

Clinical Activity ◽

Molecular Response ◽

Metastatic Squamous Cell Carcinoma

Download Full-text

Faculty Opinions recommendation of Cetuximab and bevacizumab: preclinical data and phase II trial in recurrent or metastatic squamous cell carcinoma of the head and neck.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.717954885.793461177 ◽

2012 ◽

Author(s):

Sandra Nuyts

Keyword(s):

Squamous Cell Carcinoma ◽

Cell Carcinoma ◽

Head And Neck ◽

Phase Ii ◽

Squamous Cell ◽

Phase Ii Trial ◽

Preclinical Data ◽

Metastatic Squamous Cell Carcinoma

Download Full-text